ES2663386T3 - Novirabdovirus recombinante utilizable como vector de antígenos - Google Patents
Novirabdovirus recombinante utilizable como vector de antígenos Download PDFInfo
- Publication number
- ES2663386T3 ES2663386T3 ES13799108.9T ES13799108T ES2663386T3 ES 2663386 T3 ES2663386 T3 ES 2663386T3 ES 13799108 T ES13799108 T ES 13799108T ES 2663386 T3 ES2663386 T3 ES 2663386T3
- Authority
- ES
- Spain
- Prior art keywords
- protein
- domain
- novirabdovirus
- recombinant
- rabdovirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20041—Use of virus, viral particle or viral elements as a vector
- C12N2760/20043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Novirabdovirus recombinante cuyo genoma contiene, además de los genes que codifican las proteínas N, P, M, G y L endógenas de dicho novirabdovirus, un gen exógeno que codifica una proteína quimérica, caracterizándose dicha proteína quimérica porque comprende la secuencia de una proteína antigénica de interés, no siendo dicha proteína antigénica de interés una glicoproteína, fusionada en su extremo N terminal con el péptido señal de la proteína G de un rabdovirus y en su extremo C-terminal con un fragmento de secuencia de una proteína G de rabdovirus, comprendiendo dicho fragmento el dominio transmembrana de dicha proteína G de rabdovirus o una parte de ésta que comprende al menos 15 aminoácidos C-terminales consecutivos de dicho dominio, caracterizado porque comprende además, a continuación del dominio transmembrana o de la parte de éste, el dominio intravirión de una proteína G de rabdovirus, o una parte de dicho dominio intravirión, que comprende al menos 3 aminoácidos N-terminales consecutivos de dicho dominio.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1259815A FR2996856B1 (fr) | 2012-10-15 | 2012-10-15 | Novirhabdovirus recombinant utilisable comme vecteur d'antigenes |
FR1259815 | 2012-10-15 | ||
PCT/IB2013/059207 WO2014060905A1 (fr) | 2012-10-15 | 2013-10-08 | Novirhabdovirus recombinant utilisable comme vecteur d'antigènes |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2663386T3 true ES2663386T3 (es) | 2018-04-12 |
Family
ID=48224842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES13799108.9T Active ES2663386T3 (es) | 2012-10-15 | 2013-10-08 | Novirabdovirus recombinante utilizable como vector de antígenos |
Country Status (5)
Country | Link |
---|---|
US (1) | US9907843B2 (es) |
EP (1) | EP2906704B1 (es) |
ES (1) | ES2663386T3 (es) |
FR (1) | FR2996856B1 (es) |
WO (1) | WO2014060905A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109136200B (zh) * | 2018-09-20 | 2022-02-18 | 中国水产科学研究院黑龙江水产研究所 | 一种重组传染性造血器官坏死病毒及其构建方法与应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999032648A1 (en) * | 1997-12-22 | 1999-07-01 | The University Of Tennessee Research Corporation | Recombinant rhabdovirus containing a heterologous fusion protein |
FR2839453B1 (fr) | 2002-05-07 | 2007-05-11 | Agronomique Inst Nat Rech | Utilisation de novirhabdovirus modifies pour l'obtention de vaccins |
JP4578973B2 (ja) * | 2002-09-17 | 2010-11-10 | ノバルティス アーゲー | 免疫刺激のためのihnvg蛋白質 |
EP1867725A1 (en) * | 2006-06-16 | 2007-12-19 | Institut National De La Recherche Agronomique (Inra) | Recombinant novirhabdoviruses and uses thereof |
BRPI0813194B8 (pt) * | 2007-08-03 | 2021-05-25 | Centre Nat Rech Scient | kit, partículas de vetor lentiviral, composição de vetores plasmídicos, antígeno derivado de hiv-1 quimérico, proteína de envelope de vsv-g, moléculas de ácido nucleico, composição imunogênica e uso de um vetor lentiviral |
-
2012
- 2012-10-15 FR FR1259815A patent/FR2996856B1/fr not_active Expired - Fee Related
-
2013
- 2013-10-08 WO PCT/IB2013/059207 patent/WO2014060905A1/fr active Application Filing
- 2013-10-08 US US14/435,981 patent/US9907843B2/en active Active
- 2013-10-08 EP EP13799108.9A patent/EP2906704B1/fr active Active
- 2013-10-08 ES ES13799108.9T patent/ES2663386T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
FR2996856B1 (fr) | 2015-06-05 |
EP2906704B1 (fr) | 2017-12-27 |
WO2014060905A1 (fr) | 2014-04-24 |
EP2906704A1 (fr) | 2015-08-19 |
FR2996856A1 (fr) | 2014-04-18 |
US9907843B2 (en) | 2018-03-06 |
US20150265699A1 (en) | 2015-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR122964A2 (es) | Péptidos útiles en la inmunoterapia contra el carcinoma hepatocelular (chc) y otros tipos de cáncer | |
CL2019001000A1 (es) | Proteínas de fusión fc heterodiméricas il15/il15ralfa | |
CL2018000340A1 (es) | Construcciones con un dominio sirp-alfa o sus variantes. | |
ES2600879T3 (es) | Preparaciones que contienen el factor de Von Willebrand (FvW) y procedimientos, kits y utilizaciones relacionados con las mismas | |
AR108442A1 (es) | Proteínas de fusión gdf15 y usos de estas | |
AR114339A1 (es) | Plataforma de presentación, productos y métodos con endosporas basadas en paenibacillus | |
ES2676499T3 (es) | Proteínas de fusión Fc que comprenden nuevos enlazadores o disposiciones | |
ES2545895T3 (es) | Proteína de fusión anticancerígena | |
MX2020010806A (es) | Peptidos anti-inflamatorios y usos de los mismos. | |
MX2022001134A (es) | Proteinas quimericas de factor viii y usos de estas. | |
ES2691539T3 (es) | Luciferasas de Oplophorus sintéticas con mayor emisión de luz | |
ES2676023T3 (es) | Polipéptidos de IL-22 y proteínas de fusión de IL-22 Fc y métodos de uso | |
AR080229A1 (es) | Proteinas de dominio de armazon de fibronectina que se unen a il -23 (interleucina 23) | |
MX343386B (es) | Proteinas de fusion portadoras de peptido como vacunas para alergia. | |
ES2652643T3 (es) | Péptidos terapéuticos y su uso contra la corea de Huntington | |
EA201791238A1 (ru) | Способы и композиции, в которых используются варианты полипептидов klotho | |
AR076977A1 (es) | Proteinas precursoras repetitivas autoensambladas | |
CL2017000200A1 (es) | Célula huésped mejorada para producir proteinas | |
EA201491277A1 (ru) | Противораковый слитый белок | |
JP2015524403A5 (es) | ||
NZ706884A (en) | Fc gamma receptor iib variants | |
MX2021013976A (es) | Secuencias de direccionamiento para plataforma de visualizacion de endosporas basada en paenibacillus. | |
ES2663386T3 (es) | Novirabdovirus recombinante utilizable como vector de antígenos | |
ES2572367T3 (es) | Péptidos con epítopos de la MELK y vacunas que los contienen | |
HRP20190544T1 (hr) | Ciklični analozi apelina |